In summary, our studies suggest that the synergistic expression and action of TRIB3, EGFR, and PKCα establish a TRIB3–PKCα–WWP1 regulatory axis to promote NSCLC development by enhancing EGFR recycling, stability, and signaling. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.